RNA processing is the key process determining tissue-specific activity of GLI2.
Usage of alternative transcription initiation/termination sites generates N- and C-terminally truncated GLI2.
High expression of N- and C-terminally truncated GLI2 is coupled to melanoma invasion.
RNA processing of GLI2 is TGFbeta-dependent in melanoma